2nd Annual Data Analytics and Decisions
January 23 - 24, 2019 - Philadelphia MA USCBI a division of UBM Americas
michael.berube@cbinet.com
Phone:+1-339-298-2185
Advance Analytical Tools to Strengthen Compliance Programs and Enhance Business Intelligence CBI’s 2nd Annual Data Analytics and Decisions focuses on data analytics to make strategic business decisions that will strengthen compliance monitoring and improve commercial business performance. Currently, bio/pharmaceutical and device companies are focused on streamlining their data collection practices, determining the metrics to focus on, choosing how to visualize results and analyzing best practices to filter the results. This program offers the opportunity for those with a focus on analytics, monitoring, and IT to further discuss how to integrate new technologies into the decision making of bio/pharmaceutical and device companies. Key Insights and Takeaways: Leverage data to inform competitive benchmarking Align metrics and analytics across all business units Correlate transparency data with other data sources for strategic intelligence Identify ways to ensure completeness of third-party spend including auditing aggregate spend data and underlying processes/systems Collect and manage complete and accurate data Ensure quality of data collection and systems for all related HCP payment transactions Consolidate and perfect customer master data Implement processes and systems to handle data management and reporting locally, regionally, and globally